SMTL ID : 5v4w.1

Human glucokinase in complex with novel indazole activator.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.39 Å

Oligo State

monomer

Ligands

1 x GLC: alpha-D-glucopyranose(Non-covalent)

GLC.1: 8 residues within 4Å: Chain A: N.197, D.198, I.218, G.222, C.223, N.224, E.249, E.283 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:N.197, A:N.197, A:N.224, A:E.249, A:E.283 Water bridges: A:G.222, A:N.247

1 x 8WM: (2S)-2-[4-(cyclopropylsulfonyl)-1H-indazol-1-yl]-N-(5-fluoro-1,3-thiazol-2-yl)-3-(oxan-4-yl)propanamide(Non-covalent)

8WM.2: 15 residues within 4Å: Chain A: Y.54, V.55, R.56, S.57, T.58, P.59, W.92, M.203, Y.207, H.211, M.228, L.444, K.451, K.452, M.455 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:V.55 Hydrogen bonds: A:R.56, A:R.56 pi-Stacking: A:W.92, A:W.92

1 x IOD: IODIDE ION(Non-functional Binders)

IOD.3: 4 residues within 4Å: Chain A: T.53, V.196, N.197, K.452 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cheruvallath, Z.S. et al., Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators. Bioorg. Med. Chem. Lett. (2017)

Release Date

2017-05-31

Peptides

Glucokinase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Glucokinase